JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2601
Dycom Industries
DY
$8.33B
| $4.77M | ﹤0.01% |
42,788
+18,346
| +75% | +$1.77M |
2015 Q1
11 quarters
|
|
2602
Omnicell
OMCL
$1.54B
| $4.77M | ﹤0.01% |
98,268
+47,533
| +94% | +$2.4M |
2013 Q2
18 quarters
|
|
2603
Scholastic
SCHL
$666M
| $4.77M | ﹤0.01% |
118,840
-77,621
| -40% | -$3.01M |
2015 Q3
9 quarters
|
|
2604
PUT
Nasdaq
NDAQ
$50.6B
| $4.76M | ﹤0.01% |
+186,000
| New | +$4.69M |
2017 Q4
0 quarters
|
|
2605
PUT
Boeing
BA
$152B
| $4.75M | ﹤0.01% |
16,100
+12,500
| +347% | +$3.38M |
2017 Q2
2 quarters
|
|
2606
PUT
Costco
COST
$406B
| $4.75M | ﹤0.01% |
25,500
-29,200
| -53% | -$5.04M |
2017 Q1
3 quarters
|
|
|
TCF
2607
DELISTED
TCF Financial Corporation Common Stock
TCF
| $4.74M | ﹤0.01% |
88,637
+87,084
| +5,607% | +$4.68M |
2013 Q2
18 quarters
|
|
2608
CRA International
CRAI
$1.07B
| $4.74M | ﹤0.01% |
105,351
-12,153
| -10% | -$533K |
2015 Q1
11 quarters
|
|
2609
CALL
Sarepta Therapeutics
SRPT
$1.82B
| $4.73M | ﹤0.01% |
85,000
+16,500
| +24% | +$874K |
2017 Q3
1 quarter
|
|
|
RAD
2610
DELISTED
Rite Aid Corporation
RAD
| $4.72M | ﹤0.01% |
119,766
+103,516
| +637% | +$3.7M |
2013 Q2
18 quarters
|
|
2611
PUT
United Parcel Service
UPS
$79B
| $4.72M | ﹤0.01% |
39,600
| – | – |
2016 Q4
4 quarters
|
|
2612
3D Systems Corp
DDD
$610M
| $4.72M | ﹤0.01% |
545,748
+542,846
| +18,706% | +$5.58M |
2015 Q4
8 quarters
|
|
|
LTXB
2613
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $4.7M | ﹤0.01% |
111,346
+82,444
| +285% | +$3.3M |
2015 Q3
9 quarters
|
|
|
KMG
2614
DELISTED
KMG Chemicals Inc
KMG
| $4.7M | ﹤0.01% |
71,107
+44,907
| +171% | +$2.54M |
2017 Q3
1 quarter
|
|
|
PGRE
2615
DELISTED
Paramount Group
PGRE
| $4.69M | ﹤0.01% |
295,736
+164,030
| +125% | +$2.63M |
2014 Q4
12 quarters
|
|
|
GPOR
2616
DELISTED
Gulfport Energy Corp.
GPOR
| $4.69M | ﹤0.01% |
367,334
-116,813
| -24% | -$1.55M |
2013 Q2
18 quarters
|
|
|
NUAN
2617
DELISTED
Nuance Communications, Inc.
NUAN
| $4.68M | ﹤0.01% |
330,908
-2,149,215
| -87% | -$28.9M |
2013 Q2
18 quarters
|
|
2618
Hyatt Hotels
H
$15B
| $4.68M | ﹤0.01% |
63,599
+16,927
| +36% | +$1.14M |
2013 Q2
18 quarters
|
|
|
ABAX
2619
DELISTED
Abaxis Inc
ABAX
| $4.65M | ﹤0.01% |
93,999
-3,437
| -4% | -$164K |
2015 Q4
8 quarters
|
|
2620
OneSpan
OSPN
$666M
| $4.65M | ﹤0.01% |
334,352
+23,573
| +8% | +$311K |
2015 Q4
8 quarters
|
|
|
CY
2621
CALL
DELISTED
Cypress Semiconductor
CY
| $4.65M | ﹤0.01% |
305,000
+245,000
| +408% | +$3.89M |
2017 Q3
1 quarter
|
|
|
BNY
2622
CALL
Bank of New York Mellon
BNY
$98.7B
| $4.63M | ﹤0.01% |
86,000
+81,000
| +1,620% | +$4.31M |
2017 Q3
1 quarter
|
|
2623
Tenet Healthcare
THC
$20.8B
| $4.63M | ﹤0.01% |
305,499
-46,065
| -13% | -$648K |
2013 Q2
18 quarters
|
|
2624
Silicom
SILC
$339M
| $4.63M | ﹤0.01% |
66,046
-12,656
| -16% | -$865K |
2016 Q1
7 quarters
|
|
2625
Adient
ADNT
$1.34B
| $4.63M | ﹤0.01% |
58,812
+50,696
| +625% | +$4.09M |
2016 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.